Trials / Terminated
TerminatedNCT02996760
Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.
Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- IVI Bilbao · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
Women in assisted reproduction treatment they receive own or donated embryos and presenting an endometrial development less than 5 mm despite having received treatment with estrogen therapy knowing the clinical value of using the PRGF-Endoret therapy and endometrial level applications to improve endometrial thickness endometrial preparations for embryo transfer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Growth Factor, Platelet-Derived | 0,5 mL, vaginal use , 3 dose number |
Timeline
- Start date
- 2018-03-14
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
- First posted
- 2016-12-19
- Last updated
- 2022-04-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02996760. Inclusion in this directory is not an endorsement.